CureVac files patent lawsuit in Germany against BioNTechBusiness, Lawsuits, TherapeuticsCureVac has filed a patent lawsuit in Germany against BioNTech over its use of mRNA technology, marking one of the first known cases of a company going to court amid the fierce competition to develop a vaccine against the coronavirus. Read more July 5, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/07/ReutersCureVac7-5-2022.webp 758 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-07-05 08:52:112022-07-05 09:20:15CureVac files patent lawsuit in Germany against BioNTech